The HIV+Hepatitis Policy Institute is a leading HIV and hepatitis policy organization promoting quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. We strongly support House File 3611 which would require health insurers to accept and count payments made on behalf of patients towards deductibles and out-of-pocket maximums.
Letter in support for MS SB 2470 so that patients can afford their prescription medications
[HIV+Hepatitis Policy Institute] strongly supports [MS] Senate Bill 2470, which would require health insurers to accept and count payments made on behalf of patients towards deductibles and out-of-pocket maximums and ask that you conduct a hearing on the bill as soon as possible.
Comments on drug pricing transparency interim final rule [CMS-9905-IFC]
We are pleased that the Biden administration is moving forward with the requirement that insurance plans must report on various data points associated with prescription drug spending. We believe with this greater understanding and transparency of prescription drug costs, you can better implement policies and measures that increase competition, improve prescription drug affordability and access for the American people.
Comments in support of hepatitis B universal adult vaccination
HIV+Hep strongly supports a recommendation for universal hepatitis B vaccination for all adults. The hepatitis B vaccine is safe and effective, with over 1 billion doses administered worldwide and is estimated to have prevented over 310 million infections worldwide between 1990 and 2020. Despite highly effective vaccines, up to 2.4 million people in the United States may be living with chronic hepatitis B, and there are up to 80,000 new cases of hepatitis B each year. With the proper guidance and resources, each new infection is preventable.
Letter in support of Wisconsin AB 184 so that patients can afford their prescription medications
The HIV+Hepatitis Policy Institute strongly support Assembly Bill 184, which would require health insurers and health care service contractors to accept and count payments made on behalf of patients towards deductibles and out-of-pocket maximums.